Vivo Capital, LLC Galmed Pharmaceuticals Ltd. Transaction History

Vivo Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.46 - $5.69 $2.98 Million - $4.89 Million	-860,103 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.3 - $6.84 $2.84 Million - $5.88 Million	860,103 New	860,103 $2.98 Million
Q3 2019 Nov 13, 2019	SELL	$4.62 - $7.11 $4.49 Million - $6.91 Million	-971,337 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$6.59 - $14.47 $789,778 - $1.73 Million	119,845 Added 14.07%	971,337 $6.63 Million
Q3 2018 Nov 13, 2018	BUY	$10.55 - $15.28 $620,181 - $898,234	58,785 Added 7.42%	851,492 $11.6 Million
Q2 2018 Aug 10, 2018	BUY	$5.04 - $17.96 $4 Million - $14.2 Million	792,707 New	792,707 $9.43 Million

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $82M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.